Shireen Magdy
Overview
Explore the profile of Shireen Magdy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abou-Shanab A, Gaser O, Galal N, Mohamed A, Atta D, Kamar S, et al.
Sci Rep
. 2025 Mar;
15(1):7487.
PMID: 40032892
The response of neuroblastoma (NB) cells to chemotherapeutics and their influence on NB microenvironment remain incompletely understood. Herein, we examined the underlying molecular mechanism via which Doxorubicin, a chemotherapeutic agent...
2.
Atta D, Abou-Shanab A, Kamar S, Soliman M, Magdy S, El-Badri N
J Biomed Mater Res A
. 2025 Feb;
113(2):e37882.
PMID: 39925207
Current limitations in the treatment of hepatocellular carcinoma (HCC) include tumor recurrence, chemoresistance, and severe side effects, all of which call for novel cancer models that better represent the tumor...
3.
Shouman S, El-Kholy N, Hussien A, El-Derby A, Magdy S, Abou-Shanab A, et al.
Cell Commun Signal
. 2024 Jul;
22(1):349.
PMID: 38965547
T lymphocytes play a primary role in the adaptive antiviral immunity. Both lymphocytosis and lymphopenia were found to be associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While lymphocytosis...
4.
Salah R, El-Derby A, El-Gammal Z, Wadie B, Ahmed S, Elshenawy S, et al.
Heliyon
. 2024 Feb;
10(3):e24794.
PMID: 38333871
Hepatocellular carcinoma (HCC) is one of the most prevalent cancers causing the highest mortality rate worldwide. Treatment options of surgery, radiation, cytotoxic drugs and liver transplantation suffer significant side effects...